Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom T P Seijkens

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Current Opinion in Lipidology|August 4, 2018
Cardiovascular oncology: exploring the effects of targeted cancer therapies on atherosclerosisTom T P Seijkens, Esther Lutgens
Journal for Immunotherapy of Cancer|February 9, 2020
Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular diseaseEsther Lutgens, Tom T P Seijkens
Cardiovascular Research|January 9, 2018
Exploring immune checkpoints as potential therapeutic targets in atherosclerosisPascal J H Kusters, Esther Lutgens, Tom T P Seijkens
Chinese Clinical Oncology|May 9, 2023
The emerging role for CAR T cells in solid tumor oncologySebastian Klobuch, Tom T P Seijkens, John B A G Haanen
Frontiers in Cardiovascular Medicine|June 26, 2020
E3 Ubiquitin Ligases as Immunotherapeutic Target in Atherosclerotic Cardiovascular DiseaseKikkie Poels, Winnie G Vos, Esther Lutgens, et al.
Clinical Nuclear Medicine|January 30, 2023
Peritoneal Metastases From Prostate Carcinoma Treated With 177 Lu-PSMA-I&TLarissa W van Golen, Tom T P Seijkens, Jeantine M de Feijter, et al.
Nature Reviews. Clinical Oncology|January 9, 2024
Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanomaSebastian Klobuch, Tom T P Seijkens, Ton N Schumacher, et al.
Journal of Cardiovascular Translational Research|March 31, 2020
The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular DiseaseLaura A Bosmans, Lena Bosch, Pascal J H Kusters, et al.
Med (New York, N.Y.)|May 17, 2025
Advances in TIL therapy: Expanding the horizons beyond melanomaPauline Wiertsema, Ya Hwee Tan, John B A G Haanen, et al.
European Journal of Immunology|October 16, 2020
'Nur'turing tumor T cell tolerance and exhaustion: novel function for Nuclear Receptor Nur77 in immunitySanne C Lith, Bram W van Os, Tom T P Seijkens, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Current Opinion in Lipidology|August 4, 2018
Cardiovascular oncology: exploring the effects of targeted cancer therapies on atherosclerosisTom T P Seijkens, Esther Lutgens
Journal for Immunotherapy of Cancer|February 9, 2020
Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular diseaseEsther Lutgens, Tom T P Seijkens
Cardiovascular Research|January 9, 2018
Exploring immune checkpoints as potential therapeutic targets in atherosclerosisPascal J H Kusters, Esther Lutgens, Tom T P Seijkens
Chinese Clinical Oncology|May 9, 2023
The emerging role for CAR T cells in solid tumor oncologySebastian Klobuch, Tom T P Seijkens, John B A G Haanen
Frontiers in Cardiovascular Medicine|June 26, 2020
E3 Ubiquitin Ligases as Immunotherapeutic Target in Atherosclerotic Cardiovascular DiseaseKikkie Poels, Winnie G Vos, Esther Lutgens, et al.
Clinical Nuclear Medicine|January 30, 2023
Peritoneal Metastases From Prostate Carcinoma Treated With 177 Lu-PSMA-I&TLarissa W van Golen, Tom T P Seijkens, Jeantine M de Feijter, et al.
Nature Reviews. Clinical Oncology|January 9, 2024
Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanomaSebastian Klobuch, Tom T P Seijkens, Ton N Schumacher, et al.
Journal of Cardiovascular Translational Research|March 31, 2020
The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular DiseaseLaura A Bosmans, Lena Bosch, Pascal J H Kusters, et al.
Med (New York, N.Y.)|May 17, 2025
Advances in TIL therapy: Expanding the horizons beyond melanomaPauline Wiertsema, Ya Hwee Tan, John B A G Haanen, et al.
European Journal of Immunology|October 16, 2020
'Nur'turing tumor T cell tolerance and exhaustion: novel function for Nuclear Receptor Nur77 in immunitySanne C Lith, Bram W van Os, Tom T P Seijkens, et al.
Pageof 4